Degree of hyperinsulinemia, independent of androgen levels, is an important determinant of the severity of hirsutism in PCOS
- PMID: 18722607
- PMCID: PMC3714600
- DOI: 10.1016/j.fertnstert.2008.06.021
Degree of hyperinsulinemia, independent of androgen levels, is an important determinant of the severity of hirsutism in PCOS
Abstract
Objective: To determine whether the severity in hyperandrogenemia determines, to a significant degree, the severity of hirsutism in patients with polycystic ovary syndrome (PCOS).
Design: Cross-sectional study.
Setting: Tertiary care academic referral center.
Patient(s): A total of 749 patients with PCOS.
Intervention(s): History and physical examination, blood sampling.
Main outcome measure(s): Hirsutism defined by a value of >or=6 using the modified Ferriman-Gallwey (mFG) score, age, body mass index (BMI), calculated homeostatic assessment for insulin resistance (HOMA-IR) value, and levels of total (TT) and free (FT) testosterone, dehydroepiandrosterone sulfate (DHEAS) 17-hydroxyprogesterone (17OH-P), and fasting insulin (INS) and glucose (GLC).
Result(s): Univariate correlations revealed associations between the mFG score and INS, 17OH-P, HOMA-IR, and BMI. Multivariate classification and regression tree analysis indicated that INS had the most significant association with mFG score and that at higher INS levels T played an additional role whereas at lower INS levels 17OH-P had an effect; however, this model accounted for only 8.2% of total variation in mFG score.
Conclusion(s): Insulin appears to have a direct effect on the severity of hirsutism in PCOS and appears to have a synergistic interaction with TT. Notably, over 90% of the variation in the mFG score was not related to the factors studied and likely reflects intrinsic factors related to pilosebaceous unit function or sensitivity and to other factors not yet assessed.
Figures
References
-
- Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004;89:2745–9. - PubMed
-
- Azziz R, Sanchez LA, Knochenhauer ES, Moran C, Lazenby J, Stephens KC, et al. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab. 2004;89:453–62. - PubMed
-
- Chang WY, Knochenhauer ES, Bartolucci AA, Azziz R. Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups. Fertil Steril. 2005;83:1717–23. - PubMed
-
- Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome; toward a rational approach. In: Dunaif A, Givens JR, Haseltine F, Merriam G, editors. Polycystic ovary syndrome. Blackwell Scientific; Boston: 1992. pp. 377–84.
-
- Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19–25. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
